Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity

Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity

US Patent 7465728 · Granted Dec 16, 2008

Estimated economic value: $17,796,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Quinazoline derivatives as VEGF inhibitors2019
Compounds2019
Methods of treating cancer with a pyrazole derivative2017
Quinazoline derivatives as VEGF inhibitors2015
Triazole compounds II2014
Quinazoline derivatives as VEGF inhibitors2014
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-2013
N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-2012
Quinazoline derivatives and pharmaceutical compositions containing them2011
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-2010
Pyrimidine derivatives possessing cell-cycle inhibitors activity2009
4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer2009